Emily Beman is an associate in the firm’s Technology Transactions Practice and Technology & Life Sciences Group. She joined Goodwin in 2010.

Areas of Practice




A selection of Ms. Beman’s recent representative matters is below.

  • CRISPR Therapeutics in its collaboration with Vertex Pharmaceuticals, valued up to $2.6 billion with $105 million upfront
  • CRISPR Therapeutics in its collaboration with Bayer, valued up to $635 million with $335 million upfront
  • CRISPR Therapeutics in its strategic in-licensing and collaboration agreement with Anagenesis Biotechnologies
  • F-star Alpha in its exclusive purchase option agreement with Bristol-Myers Squibb with potential deal value up to $475 million
  • Naurex in its $560 million sale to Allergan
  • Cephalon in its exclusive license agreement with Eagle Pharmaceuticals with a total deal value in excess of $120 million, plus royalties
  • Teva Pharmaceuticals, in its $40.5 billion acquisition of Allergan’s (fka Actavis/Watson) Global Generic Pharmaceuticals Business.
  • Teva Pharmaceuticals, in connection with its sale of oncology assets to Ignyta
  • Teva Pharmaceuticals, in connection with patent license and settlement agreements related to settlements of various brand and generic pharmaceutical patent litigation matters
  • Licensing of intellectual property assets from research institutions
Professional Experience

Prior to joining Goodwin, Ms. Beman was a Special Assistant District Attorney in the Kings County District Attorney’s Office.


While in law school, Ms. Beman was the Alumni Affairs Editor of the Connecticut Law Review.

In The News

In den Nachrichten






J.D., 2009
University of Connecticut School of Law


B.S., Chemistry, 2006
Trinity College



New York
U.S. Patent and Trademark Office (USPTO)
Get In Touch
In Kontakt kommen
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.


Search Other Lawyers
Suche Andere Rechtsanwälte